Page last updated: 2024-10-30

labetalol and Fusiform Aneurysm

labetalol has been researched along with Fusiform Aneurysm in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Fusiform Aneurysm: Elongated, spindle-shaped dilation in the wall of blood vessels, usually large ARTERIES with ATHEROSCLEROSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, A1
Shimano, Y1
Otsuka, Y1
Kato, M1
Usami, T1
Takeuchi, O1
Koyama, K1
Morozumi, K1
Sano, T1
Fukazu, A1
Kimura, G1

Other Studies

1 other study available for labetalol and Fusiform Aneurysm

ArticleYear
A case of renovascular hypertension due to bilateral renal artery microaneurysm who succeeded in baby delivery.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2001, Volume: 24, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aneurysm; Angiography; Female; Humans; Hypertension, Renovascula

2001